Foley Hoag LLP advised Genialis on the deal. Genialis, a computational precision medicine company, announced its $13M Series A financing led by Debiopharm Innovatoin Fund and Taiwania...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here